Is TOVX or TRVI more undervalued in 2026?

CirclFi compares Theriva Biologics, Inc. (TOVX) and Trevi Therapeutics, Inc. (TRVI) using 13 institutional-grade valuation models. TOVX has a Quality of Company score of 4.0/10 while TRVI scores 4.2/10.

Which is a better buy — TOVX or TRVI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TOVX and TRVI valuations compare?

TOVX at $0.28 and TRVI at $14.14 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TOVX vs TRVI Valuation Comparison 2026 — Intrinsic Value Analysis

TOVX

Pharmaceutical Preparations

Theriva Biologics, Inc.

Quality

4.0

out of 10

Value Trap

LOW

Price

$0.28

Last close

Models

8/13

Active

TRVI

Pharmaceutical Preparations

Trevi Therapeutics, Inc.

Quality

4.2

out of 10

Value Trap

LOW

Price

$14.14

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	TOVX Fair Value	TOVX Upside	TRVI Fair Value	TRVI Upside
Bayesian DCF	Intrinsic	$0.23	-18.8%	$3.83	-72.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.05	-87.6%	$0.36	-97.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TOVX vs TRVI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TOVX vs TRVI — Which Stock Is More Undervalued?

TRVI scores higher with a 4.2/10 quality rating vs TOVX's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Theriva Biologics, Inc. (TOVX) and Trevi Therapeutics, Inc. (TRVI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TOVX currently trades at $0.28 with a QOC of 4.0/10, while TRVI trades at $14.14 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).